India’s Malaria Elimination Success and Public Health Transformation Using sustainable health outcomes and community impact strategies—ESG BROADCAST shares key takeaways.
India’s public health sector is registering a historic reduction in malaria incidence and mortality, signaling that elimination of the disease is within reach. Union Home Minister Amit Shah reaffirmed that India has achieved an approximately 97 % decline in malaria cases compared with past baselines, a milestone resulting from national health policy implementation and comprehensive disease control measures. Leaders now project that India could become nearly malaria-free in a short time, marking a major public health success story.
At the IMA NATCON 2025 held in Ahmedabad, Amit Shah credited this achievement to the effective rollout of flagship schemes such as Ayushman Bharat and Mission Indradhanush, which have expanded preventive care, vaccination, and treatment coverage across the country. During his address, Shah highlighted concurrent improvements in key public health metrics, including a reduction in dengue mortality to 1 % and a 25 % decline in maternal mortality, reflecting the broad impact of strengthened health systems.
These gains align with long-term strategic frameworks such as the National Framework for Malaria Elimination (2016–2030) and subsequent National Strategic Plans aimed at achieving zero indigenous malaria cases by 2027 and complete elimination by 2030. These strategies emphasize data-driven surveillance, enhanced diagnosis and treatment access, targeted vector control, and sustained public health financing.
Independent epidemiological data reaffirm the magnitude of progress: from 2015 to 2024, malaria cases decreased from an estimated 1.17 million to about 227,000, an 80–85 % decline, while malaria-related deaths fell by roughly 78 %. Additionally, more than 92 % of districts now report Annual Parasite Incidence (API) below 1, indicating that India is largely in the pre-elimination phase—where localized, targeted responses replace broad control campaigns.
While progress is remarkable, operational challenges remain as transmission becomes increasingly focal—the disease persists in small, specific geographic pockets shaped by local ecology, human mobility, and healthcare access variations. Ensuring consistent private sector reporting, expanding entomological capacity, and enhancing urban malaria control will be crucial next steps in India’s elimination trajectory.
Globally, India’s achievements also help reshape malaria control dynamics. The World Health Organization’s global malaria reports have documented similar downward trends in India’s malaria burden, supporting India’s exit from the WHO’s High Burden to High Impact (HBHI) group in recent years. This reflects both disease reduction and improved health system responsiveness.
Strategic significance lies in the systemic transformation these results indicate for India’s healthcare landscape. Near-elimination of a historically endemic disease demonstrates the effectiveness of sustained investment, multisectoral coordination, and community engagement. For ESG stakeholders, progress toward a malaria-free India enhances health equity and community resilience, strengthens public health infrastructure, and unlocks socio-economic value by reducing disease burden and healthcare costs. As India moves closer to meeting its elimination targets, continued focus on localized interventions and cross-sector partnerships will be key to securing long-term public health outcomes that underpin national and regional development goals.
